Publication Name	World Journal of Diabetes
Manuscript ID	98876
Country	China

Received	2024-07-08 09:53
Peer-Review Started	2024-07-08 09:53
To Make the First Decision
Return for Revision	2024-09-07 23:50
Revised	2024-09-13 18:21
Second Decision	2024-10-12 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-12 08:27
Articles in Press	2024-10-12 08:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-29 16:30
Publish the Manuscript Online	2024-11-18 03:30

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Letter to the Editor
Article Title	Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management
Manuscript Source	Invited Manuscript
All Author List	Ke-Xin Zhang, Cheng-Xia Kan, Yu-Qun Wang, Ning-Ning Hou and Xiao-Dong Sun
ORCID	Author(s) ORCID Number Ke-Xin Zhang http://orcid.org/0000-0002-9224-9465 Cheng-Xia Kan http://orcid.org/0000-0002-4593-0303 Yu-Qun Wang http://orcid.org/0000-0002-7380-3803 Ning-Ning Hou http://orcid.org/0000-0002-3813-8465 Xiao-Dong Sun http://orcid.org/0000-0001-7775-2823
Funding Agency and Grant Number
Corresponding Author	Xiao-Dong Sun, MD, PhD, Department of Endocrinology and Metabolism, The Affiliated Hospital of Shandong Second Medical University, No. 2428 Yuhe Road, Weifang 261031, Shandong Province, China. xiaodong.sun@sdsmu.edu.cn
Key Words	Type 1 diabetes; Glucagon-like peptide-1; Hypoglycemia; Hypoglycemic counterregulation; Hormonal reaction
Core Tip	Elevated intestinal glucagon-like peptide-1 impairs hypoglycemic counterregulation in type 1 diabetes by reducing glucagon and adrenaline secretion. This highlights the need for a balanced approach to glucagon-like peptide-1-based therapies, considering both glycemic control and the risk of hypoglycemia.
Publish Date	2024-11-18 03:30
Citation	<p>Zhang KX, Kan CX, Wang YQ, Hou NN, Sun XD. Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management. <i>World J Diabetes</i> 2024; 15(12): 2380-2383</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i12/2380.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i12.2380

Full Article (PDF)	WJD-15-2380-with-cover.pdf
Manuscript File	98876_Auto_Edited_074514.docx
Answering Reviewers	98876-answering-reviewers.pdf
Audio Core Tip	98876-audio.mp3
Conflict-of-Interest Disclosure Form	98876-conflict-of-interest-statement.pdf
Copyright License Agreement	98876-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98876-non-native-speakers.pdf
Peer-review Report	98876-peer-reviews.pdf
Scientific Misconduct Check	98876-scientific-misconduct-check.png
Scientific Editor Work List	98876-scientific-editor-work-list.pdf
CrossCheck Report	98876-crosscheck-report.png
CrossCheck Report	98876-crosscheck-report.pdf